Cargando…
Creatine phosphokinase elevation exacerbated by levetiracetam therapy
A 19-year-old muscular male with a history of epilepsy presented following two convulsive events. Levetiracetam (LEV) was given as an additional therapy, resulting in a marked boost in creatine phosphokinase (CPK) that could not easily be explained by renal dysfunction or rhabdomyolysis alone. Levet...
Autores principales: | Isaacson, Julia E., Choe, Dongwhoon J., Doherty, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308055/ https://www.ncbi.nlm.nih.gov/pubmed/25667904 http://dx.doi.org/10.1016/j.ebcr.2014.09.008 |
Ejemplares similares
-
Relationship of Levetiracetam and Serum Creatine Phosphokinase in Children with Epilepsy
por: Panda, Prateek Kumar, et al.
Publicado: (2021) -
Effect of Levetiracetam Usage on Serum Creatine Phosphokinase Concentration in Patients with Epilepsy
por: Incecik, Faruk, et al.
Publicado: (2020) -
ELEVATED CREATINE PHOSPHOKINASE IN PATIENTS WITH COVID-19
por: BHALLA, SUSHEN, et al.
Publicado: (2022) -
PLASMA CREATINE PHOSPHOKINASE IN SCHIZOPHRENIA
por: Kondaiah, P., et al.
Publicado: (1981) -
Physiologic Response to Exercise or Rhabdomyolysis? Creatine Phosphokinase Elevation in 16 Asymptomatic Firefighters
por: Arbab, Rajia, et al.
Publicado: (2022)